CHRISTINA HALL: Open Payments
NPI 1437752821 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,710 in 81 payments from 35 companies in 2025. Trend: 2023 $830 · 2024 $1,519 · 2025 $1,710
Food & beverage: $1,635Education: $75
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $212 |
| Daiichi Sankyo Inc. | 9 | $191 |
| Janssen Biotech, Inc. | 6 | $141 |
| Incyte Corporation | 3 | $86 |
| Astellas Pharma US Inc | 3 | $73 |
| Genentech USA, Inc. | 3 | $72 |
| Blueprint Medicines Corporation | 2 | $60 |
| ABBVIE INC. | 3 | $56 |
| GENZYME CORPORATION | 3 | $52 |
| Syndax Pharmaceuticals, Inc. | 2 | $52 |
Products named: Enhertu, KISQALI, Fabhalta, INJECTAFER, CARVYKTI, AYVAKIT, MONJUVI, Vyloy.
Industry payments across KY — which companies pay providers there.
